Stay updated on Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The terms 'Head and neck squamous cell carcinoma' and the related topic 'MedlinePlus Genetics' have been removed from the page.
    Difference
    0.2%
    Check dated 2025-12-02T17:23:39.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Related topics were added (Head and neck squamous cell carcinoma; MedlinePlus Genetics) and the page revision label updated from v3.2.0 to v3.3.2. These are metadata updates and do not affect the study details.
    Difference
    0.2%
    Check dated 2025-11-25T13:31:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which was an operational status message. This change does not affect the study details or eligibility information, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The related topics list on the page no longer includes 'Head and neck squamous cell carcinoma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-11T03:13:26.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added related topics: Head and neck squamous cell carcinoma and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:30:44.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Head and neck squamous cell carcinoma and related topics: MedlinePlus Genetics were removed from the page.
    Difference
    0.7%
    Check dated 2025-10-27T20:54:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Head and Neck Cancer Clinical Trial page.